ATRC
HealthcareAtriCure, Inc.
$30.41+0.56 (+1.89%)
Prev Close
$29.84
Open
$30.19
High
$30.85
Low
$29.88
Volume
100.7K
Market Cap
$1.47B
P/E
—
Div Yield
—
Over the past 12 months, insider activity at AtriCure, Inc. (ATRC) has been exclusively selling, with 0 insider purchases totaling $0.00 and 10 insider sales totaling $1.56M. The most recent insider transaction was by Doraiswamy Vinayak (officer: Chief Scientific Officer), who sold $149.2K worth of shares on Mar 16, 2026. AtriCure, Inc. operates in the Healthcare sector, within the Medical - Instruments & Supplies industry, with a market cap of $1.47B.
Buys (12M)
0
$0.00
Sells (12M)
10
$1.56M
Net Activity
Net Seller
$1.56M
Active Insiders
5
last 12 mo
ATRC Price Chart
ATRC Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 16, 2026↗ | Doraiswamy Vinayak | officer: Chief Scientific Officer | Sell | 5,000 | $29.83 | $149.2K | 96,875 |
| Nov 26, 2025↗ | Noznesky Justin J | Chief Mktg & Strategy Officer | Sell | 5,166 | $37.29 | $192.6K | 0 |
| Nov 24, 2025↗ | WEHRWEIN SVEN | Director | Sell | 10,000 | $37.66 | $376.6K | 0 |
| Nov 21, 2025↗ | Yuen Maggie | Director | Sell | 3,000 | $35.72 | $107.2K | 0 |
| Sep 12, 2025↗ | Noznesky Justin J | Chief Mktg & Strategy Officer | Sell | 3,000 | $36.30 | $108.9K | 0 |
| Aug 22, 2025↗ | WEHRWEIN SVEN | Director | Sell | 5,000 | $37.00 | $185.0K | 0 |
| Aug 19, 2025↗ | WEHRWEIN SVEN | Director | Sell | 5,000 | $36.00 | $180.0K | 0 |
| Aug 6, 2025↗ | GROVES REGINA E | Director | Sell | 2,452 | $36.82 | $90.3K | 0 |
| Aug 5, 2025↗ | Doraiswamy Vinayak | Chief Scientific Officer | Sell | 2,500 | $36.58 | $91.5K | 0 |
| May 28, 2025↗ | Doraiswamy Vinayak | Chief Scientific Officer | Sell | 2,500 | $33.44 | $83.6K | 0 |
| Mar 5, 2025↗ | Prange Karen | Director | Sell | 6,100 | $38.12 | $232.5K | 0 |
| Mar 1, 2025↗ | CARREL MICHAEL H | President, CEO, & Director | Sell | 43,926 | $38.74 | $1.70M | 0 |
| Mar 1, 2025↗ | Dahlquist Karl S. | Chief Legal Officer | Sell | 9,870 | $38.74 | $382.4K | 0 |
| Mar 1, 2025↗ | Doraiswamy Vinayak | Chief Scientific Officer | Sell | 9,672 | $38.74 | $374.7K | 0 |
| Mar 1, 2025↗ | Noznesky Justin J | Chief Mktg & Strategy Officer | Sell | 9,673 | $38.74 | $374.7K | 0 |
| Mar 1, 2025↗ | Privitera Salvatore | Chief Technical Officer | Sell | 8,397 | $38.74 | $325.3K | 0 |
| Mar 1, 2025↗ | Seith Douglas J | Chief Operating Officer | Sell | 15,050 | $38.74 | $583.0K | 0 |
| Mar 1, 2025↗ | Wirick Angela L | Chief Financial Officer | Sell | 13,633 | $38.74 | $528.1K | 0 |
| Mar 1, 2025↗ | Yount Deborah Lee | Chief Human Resources Officer | Sell | 11,961 | $38.74 | $463.4K | 0 |
| Aug 15, 2024↗ | Yuen Maggie | Director | Sell | 3,500 | $24.07 | $84.2K | 0 |
| May 30, 2024↗ | Privitera Salvatore | Chief Technical Officer | Buy | 5,000 | $22.25 | $111.3K | 0 |
| May 1, 2024↗ | Noznesky Justin J | Chief Mktg & Strategy Officer | Sell | 1,500 | $24.09 | $36.1K | 0 |
| Apr 1, 2024↗ | Noznesky Justin J | Chief Mktg & Strategy Officer | Sell | 1,500 | $30.39 | $45.6K | 0 |
| Mar 18, 2024↗ | Dahlquist Karl S. | Chief Legal Officer | Sell | 1,885 | $32.16 | $60.6K | 0 |
| Mar 12, 2024↗ | Noznesky Justin J | Chief Mktg & Strategy Officer | Sell | 1,500 | $36.72 | $55.1K | 0 |
| Mar 5, 2024↗ | Dahlquist Karl S. | Chief Legal Officer | Sell | 8,231 | $37.36 | $307.5K | 0 |
| Mar 1, 2024↗ | CARREL MICHAEL H | President, CEO, & Director | Sell | 47,824 | $36.28 | $1.74M | 0 |
| Mar 1, 2024↗ | Doraiswamy Vinayak | Chief Scientific Officer | Sell | 8,855 | $36.28 | $321.3K | 0 |
| Mar 1, 2024↗ | Noznesky Justin J | Chief Mktg & Strategy Officer | Sell | 8,856 | $36.28 | $321.3K | 0 |
| Mar 1, 2024↗ | Privitera Salvatore | Chief Technical Officer | Sell | 7,354 | $36.28 | $266.8K | 0 |
| Mar 1, 2024↗ | Seith Douglas J | Chief Operating Officer | Sell | 14,596 | $36.28 | $529.5K | 0 |
| Nov 1, 2023↗ | Dahlquist Karl S. | Chief Legal Officer | Sell | 1,248 | $34.43 | $43.0K | 0 |
| Aug 6, 2023↗ | Wirick Angela L | Chief Financial Officer | Sell | 5,191 | $57.23 | $297.1K | 0 |
| Jul 26, 2023↗ | Dahlquist Karl S. | Chief Legal Officer | Sell | 3,417 | $57.09 | $195.1K | 0 |
| Jun 8, 2023↗ | Prange Karen | Director | Sell | 713 | $47.89 | $34.1K | 0 |
| Jun 6, 2023↗ | Dahlquist Karl S. | Chief Legal Officer | Sell | 1,422 | $47.03 | $66.9K | 0 |
| Jun 1, 2023↗ | Yount Deborah Lee | Chief Human Resources Officer | Sell | 5,240 | $34.02 | $178.3K | 0 |
| May 26, 2023↗ | Yuen Maggie | Director | Sell | 4,313 | $47.04 | $202.9K | 0 |
| May 1, 2023↗ | Dahlquist Karl S. | Chief Legal Officer | Sell | 4,417 | $44.83 | $198.0K | 0 |
| Mar 1, 2023↗ | CARREL MICHAEL H | President, CEO, & Director | Sell | 45,470 | $38.81 | $1.76M | 0 |
| Mar 1, 2023↗ | Dahlquist Karl S. | Chief Legal Officer | Sell | 6,894 | $38.81 | $267.6K | 0 |
| Mar 1, 2023↗ | Doraiswamy Vinayak | Chief Scientific Officer | Sell | 4,793 | $38.81 | $186.0K | 0 |
| Mar 1, 2023↗ | Noznesky Justin J | Chief Mktg & Strategy Officer | Sell | 7,083 | $38.81 | $274.9K | 0 |
| Mar 1, 2023↗ | Privitera Salvatore | Chief Technical Officer | Sell | 6,314 | $38.81 | $245.0K | 0 |
| Mar 1, 2023↗ | Seith Douglas J | Chief Operating Officer | Sell | 11,687 | $38.81 | $453.6K | 0 |
| Mar 1, 2023↗ | Wirick Angela L | Chief Financial Officer | Sell | 3,532 | $38.81 | $137.1K | 0 |
| Sep 15, 2022↗ | Doraiswamy Vinayak | Chief Scientific Officer | Sell | 4,983 | $45.99 | $229.2K | 0 |
| Aug 6, 2022↗ | Wirick Angela L | Chief Financial Officer | Sell | 5,191 | $50.94 | $264.4K | 0 |
| May 13, 2022↗ | Austin Tonya | Chief Human Resources Officer | Sell | 3,203 | $42.69 | $136.7K | 0 |
| Apr 8, 2022↗ | Austin Tonya | Chief Human Resources Officer | Sell | 282 | $61.59 | $17.4K | 0 |
Showing 1–50 of 92
1 / 2
ATRC Insider Buying Activity
The following table shows recent insider purchases of AtriCure, Inc. (ATRC) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| May 30, 2024↗ | Privitera Salvatore | Chief Technical Officer | Buy | 5,000 | $22.25 | $111.3K | 0 |
ATRC Insider Selling Activity
The following table shows recent insider sales of AtriCure, Inc. (ATRC) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 16, 2026↗ | Doraiswamy Vinayak | officer: Chief Scientific Officer | Sell | 5,000 | $29.83 | $149.2K | 96,875 |
| Nov 26, 2025↗ | Noznesky Justin J | Chief Mktg & Strategy Officer | Sell | 5,166 | $37.29 | $192.6K | 0 |
| Nov 24, 2025↗ | WEHRWEIN SVEN | Director | Sell | 10,000 | $37.66 | $376.6K | 0 |
| Nov 21, 2025↗ | Yuen Maggie | Director | Sell | 3,000 | $35.72 | $107.2K | 0 |
| Sep 12, 2025↗ | Noznesky Justin J | Chief Mktg & Strategy Officer | Sell | 3,000 | $36.30 | $108.9K | 0 |
| Aug 22, 2025↗ | WEHRWEIN SVEN | Director | Sell | 5,000 | $37.00 | $185.0K | 0 |
| Aug 19, 2025↗ | WEHRWEIN SVEN | Director | Sell | 5,000 | $36.00 | $180.0K | 0 |
| Aug 6, 2025↗ | GROVES REGINA E | Director | Sell | 2,452 | $36.82 | $90.3K | 0 |
| Aug 5, 2025↗ | Doraiswamy Vinayak | Chief Scientific Officer | Sell | 2,500 | $36.58 | $91.5K | 0 |
| May 28, 2025↗ | Doraiswamy Vinayak | Chief Scientific Officer | Sell | 2,500 | $33.44 | $83.6K | 0 |
| Mar 5, 2025↗ | Prange Karen | Director | Sell | 6,100 | $38.12 | $232.5K | 0 |
| Mar 1, 2025↗ | CARREL MICHAEL H | President, CEO, & Director | Sell | 43,926 | $38.74 | $1.70M | 0 |
| Mar 1, 2025↗ | Dahlquist Karl S. | Chief Legal Officer | Sell | 9,870 | $38.74 | $382.4K | 0 |
| Mar 1, 2025↗ | Doraiswamy Vinayak | Chief Scientific Officer | Sell | 9,672 | $38.74 | $374.7K | 0 |
| Mar 1, 2025↗ | Noznesky Justin J | Chief Mktg & Strategy Officer | Sell | 9,673 | $38.74 | $374.7K | 0 |
| Mar 1, 2025↗ | Privitera Salvatore | Chief Technical Officer | Sell | 8,397 | $38.74 | $325.3K | 0 |
| Mar 1, 2025↗ | Seith Douglas J | Chief Operating Officer | Sell | 15,050 | $38.74 | $583.0K | 0 |
| Mar 1, 2025↗ | Wirick Angela L | Chief Financial Officer | Sell | 13,633 | $38.74 | $528.1K | 0 |
| Mar 1, 2025↗ | Yount Deborah Lee | Chief Human Resources Officer | Sell | 11,961 | $38.74 | $463.4K | 0 |
| Aug 15, 2024↗ | Yuen Maggie | Director | Sell | 3,500 | $24.07 | $84.2K | 0 |
| May 1, 2024↗ | Noznesky Justin J | Chief Mktg & Strategy Officer | Sell | 1,500 | $24.09 | $36.1K | 0 |
| Apr 1, 2024↗ | Noznesky Justin J | Chief Mktg & Strategy Officer | Sell | 1,500 | $30.39 | $45.6K | 0 |
| Mar 18, 2024↗ | Dahlquist Karl S. | Chief Legal Officer | Sell | 1,885 | $32.16 | $60.6K | 0 |
| Mar 12, 2024↗ | Noznesky Justin J | Chief Mktg & Strategy Officer | Sell | 1,500 | $36.72 | $55.1K | 0 |
| Mar 5, 2024↗ | Dahlquist Karl S. | Chief Legal Officer | Sell | 8,231 | $37.36 | $307.5K | 0 |
| Mar 1, 2024↗ | CARREL MICHAEL H | President, CEO, & Director | Sell | 47,824 | $36.28 | $1.74M | 0 |
| Mar 1, 2024↗ | Doraiswamy Vinayak | Chief Scientific Officer | Sell | 8,855 | $36.28 | $321.3K | 0 |
| Mar 1, 2024↗ | Noznesky Justin J | Chief Mktg & Strategy Officer | Sell | 8,856 | $36.28 | $321.3K | 0 |
| Mar 1, 2024↗ | Privitera Salvatore | Chief Technical Officer | Sell | 7,354 | $36.28 | $266.8K | 0 |
| Mar 1, 2024↗ | Seith Douglas J | Chief Operating Officer | Sell | 14,596 | $36.28 | $529.5K | 0 |
| Nov 1, 2023↗ | Dahlquist Karl S. | Chief Legal Officer | Sell | 1,248 | $34.43 | $43.0K | 0 |
| Aug 6, 2023↗ | Wirick Angela L | Chief Financial Officer | Sell | 5,191 | $57.23 | $297.1K | 0 |
| Jul 26, 2023↗ | Dahlquist Karl S. | Chief Legal Officer | Sell | 3,417 | $57.09 | $195.1K | 0 |
| Jun 8, 2023↗ | Prange Karen | Director | Sell | 713 | $47.89 | $34.1K | 0 |
| Jun 6, 2023↗ | Dahlquist Karl S. | Chief Legal Officer | Sell | 1,422 | $47.03 | $66.9K | 0 |
| Jun 1, 2023↗ | Yount Deborah Lee | Chief Human Resources Officer | Sell | 5,240 | $34.02 | $178.3K | 0 |
| May 26, 2023↗ | Yuen Maggie | Director | Sell | 4,313 | $47.04 | $202.9K | 0 |
| May 1, 2023↗ | Dahlquist Karl S. | Chief Legal Officer | Sell | 4,417 | $44.83 | $198.0K | 0 |
| Mar 1, 2023↗ | CARREL MICHAEL H | President, CEO, & Director | Sell | 45,470 | $38.81 | $1.76M | 0 |
| Mar 1, 2023↗ | Dahlquist Karl S. | Chief Legal Officer | Sell | 6,894 | $38.81 | $267.6K | 0 |
| Mar 1, 2023↗ | Doraiswamy Vinayak | Chief Scientific Officer | Sell | 4,793 | $38.81 | $186.0K | 0 |
| Mar 1, 2023↗ | Noznesky Justin J | Chief Mktg & Strategy Officer | Sell | 7,083 | $38.81 | $274.9K | 0 |
| Mar 1, 2023↗ | Privitera Salvatore | Chief Technical Officer | Sell | 6,314 | $38.81 | $245.0K | 0 |
| Mar 1, 2023↗ | Seith Douglas J | Chief Operating Officer | Sell | 11,687 | $38.81 | $453.6K | 0 |
| Mar 1, 2023↗ | Wirick Angela L | Chief Financial Officer | Sell | 3,532 | $38.81 | $137.1K | 0 |
| Sep 15, 2022↗ | Doraiswamy Vinayak | Chief Scientific Officer | Sell | 4,983 | $45.99 | $229.2K | 0 |
| Aug 6, 2022↗ | Wirick Angela L | Chief Financial Officer | Sell | 5,191 | $50.94 | $264.4K | 0 |
| May 13, 2022↗ | Austin Tonya | Chief Human Resources Officer | Sell | 3,203 | $42.69 | $136.7K | 0 |
| Apr 8, 2022↗ | Austin Tonya | Chief Human Resources Officer | Sell | 282 | $61.59 | $17.4K | 0 |
ATRC Insiders
Similar Stocks to ATRC
ISRG
Intuitive Surgical, Inc.
$481.62+1.97%
$170.20B
BDX
Becton, Dickinson and Company
$161.03+1.07%
$57.83B
RMD
ResMed Inc.
$230.29-0.24%
$33.92B
MDLN
Medline Inc.
$41.84+0.92%
$33.33B
WST
West Pharmaceutical Services, Inc.
$240.64+2.20%
$16.96B
HOLX
Hologic, Inc.
$75.20+0.11%
$16.77B
COO
The Cooper Companies, Inc.
$70.61+0.99%
$13.64B
MASI
Masimo Corporation
$175.47-0.01%
$9.42B